Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 8-K Event Agreement ended · Exit or restructuring costs
  2. 8-K Event Regulation FD disclosure · Other events
  3. EFFECT Other Notice of Effectiveness
  4. S-3 Offering Registration Statement
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. 8-K Event Regulation FD disclosure
  8. DRS Other Draft Registration Statement
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations · Regulation FD disclosure
  12. 4 Open-market sale Director sold 32,300 shares at an average $2.33 ($75,240)
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 8-K Event Regulation FD disclosure · Other events
  16. 144 Insider Sale of Securities
  17. 4 Open-market sale Director sold 6,400 shares at $2.23 ($14,273)
  18. 144 Insider Sale of Securities
  19. 4 Grant or award Director acquired 35,500 shares (grant or award)
  20. 4 Grant or award Director acquired 35,500 shares (grant or award)

Page 1 of 19 · 365 filings